Table 2. Relationships between prognostic model associated IRGs and clinical variables of patients with BLCA.
| Variables | Age (≤65/≥65) t(p) | Gender (Female/Male) t(p) | Pathological grade (High grade/Low grade) t(p) | Clinical stage (3&4/1&2) t(p) | Tumor stage (T3&4/T1&2) t(p) | Lymph nodes (N1&2/N0) t(p) |
| TAP1 | 1.132(0.259) | -0.104(0.917) | 9.129(3.073e-13) | 1.298(0.197) | 1.006(0.316) | 1.492(0.137) |
| MMP9 | -0.974(0.331) | -0.888(0.376) | 1.663(0.097) | -1.16(0.247) | -1.206(0.229) | -1.003(0.318) |
| ADIPOQ | -2.377(0.018) | 1.167(0.246) | 3.645(3.115e-04) | -0.339(0.735) | -0.662(0.509) | 0.233(0.816) |
| PDGFRA | 0.366(0.714) | 1.446(0.150) | 4.534(9.997e-05) | -3.645(3.199e-04) | -4.011(7.503e-05) | -1.492(0.137) |
| AHNAK | 0.087(0.931) | 0.901(0.369) | 6.793(2.305e-07) | -3.435(7.172e-04) | -2.989(0.003) | -2.321(0.021) |
| OLR1 | -0.016(0.987) | -0.369(0.712) | 2.12(0.047) | -1.851(0.066) | -2.358(0.019) | -0.388(0.698) |
| RAC3 | -1.8(0.073) | 0.886(0.377) | 4.227(1.542e-04) | -1.774(0.078) | -1.059(0.291) | -0.581(0.562) |
| IL34 | -0.849(0.397) | 0.352(0.725) | 5.066(7.503e-07) | -1.974(0.049) | -2.444(0.015) | -2.053(0.042) |
| NAMPT | -0.698(0.486) | 2.224(0.028) | 4.5(1.488e-04) | -1.933(0.054) | -1.62(0.106) | 0.682(0.495) |
| PPY | -1.385(0.167) | -0.174(0.862) | 4.995(9.603e-07) | -1.524(0.128) | -1.795(0.074) | 0.139(0.890) |
| SH3BP2 | 0.983(0.327) | -2.401(0.017) | -0.586(0.566) | 2.384(0.019) | 1.327(0.186) | 1.974(0.049) |
| Risk Score | -1.426(0.155) | 1.464(0.146) | 5.272(2.433e-07) | -4.304(2.323e-05) | -3.926(1.101e-04) | -1.371(0.172) |
t, t value determined using the Student t test; p, p value determined using the Student t test.